Regulating the Pharmaceutical Industry: An Analysis of the Drug Regulatory Authority of Pakistan (DRAP)

Shahid Mehmood

MPRA Paper from University Library of Munich, Germany

Abstract: Healthy lives and the longevity of humans over time have critically been dependent upon the availability of quality drugs. Therefore, regulating the pharmaceutical industry for ensuring quality drugs and quality services (like drug dispensing) have traditionally been a priority for governments all around the globe. Pakistan is no exception, and at present has DRAP as its regulator of the pharmaceutical industry. Founded in 2012, few studies have analysed the performance of DRAP to date, and even those are limited in content, coverage and data. In sum aggregate, DRAPs performance is better than its predecessor, but there are still significant gaps to be filled and significant challenges to be addressed.

Keywords: Pakistan Pharmaceutical Industry; Pharmaceutical Regulation; Regulation; DRAP; Pakistan; Medicines (search for similar items in EconPapers)
JEL-codes: I18 I3 I38 (search for similar items in EconPapers)
Date: 2022-04-15
New Economics Papers: this item is included in nep-dem
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/113416/1/MPRA_paper_113416.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:113416

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().